Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF
Clinical trial NCT03794518 · UNKNOWN
Trial details
- NCT number
- NCT03794518
- Sponsor
- Hamad Medical Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2021-09-01
- Enrollment
- 648
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.